Conversion of proteolytically modified form (Lys-form) of human plasminogen to plasmin by urokinase in the presence of tranexamic acid.
D000596:Amino Acids / Q000494:pharmacology; D015119:Aminocaproic Acid / Q000494:pharmacology; D010450:Endopeptidases / Q000494:pharmacology*; D005341:Fibrinolysin / Q000378:metabolism*; D006801:Humans; D006868:Hydrolysis; D009842:Oligopeptides / Q000378:metabolism; D010447:Peptide Hydrolases / Q000494:pharmacology*; D010958:Plasminogen / Q000378:metabolism*; D011487:Protein Conformation; D014148:Tranexamic Acid / Q000494:pharmacology; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology*
D000596:Amino Acids; D009842:Oligopeptides; C018788:valyl-leucyl-lysine 4-nitroanilide; D014148:Tranexamic Acid; D010958:Plasminogen; D010450:Endopeptidases; D010447:Peptide Hydrolases; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator; D015119:Aminocaproic Acid